These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29966439)

  • 1. Five-year observation of the relationship between body mass index and glycated hemoglobin in children with Type 1 diabetes mellitus.
    Kadłubiska A; Małachowska B; Noiszewska K; Fendler W; Głowińska-Olszewska B; Bossowski A; Łuczyński W
    Scand J Clin Lab Invest; 2018 Sep; 78(5):398-406. PubMed ID: 29966439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes.
    Mortensen HB; Robertson KJ; Aanstoot HJ; Danne T; Holl RW; Hougaard P; Atchison JA; Chiarelli F; Daneman D; Dinesen B; Dorchy H; Garandeau P; Greene S; Hoey H; Kaprio EA; Kocova M; Martul P; Matsuura N; Schoenle EJ; Søvik O; Swift PG; Tsou RM; Vanelli M; Aman J
    Diabet Med; 1998 Sep; 15(9):752-9. PubMed ID: 9737804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
    Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body composition in children with type 1 diabetes in the first year after diagnosis: relationship to glycaemic control and cardiovascular risk.
    Davis NL; Bursell JD; Evans WD; Warner JT; Gregory JW
    Arch Dis Child; 2012 Apr; 97(4):312-5. PubMed ID: 22294667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving target levels for vascular risk parameters in Polish school-age children with type 1 diabetes - a single center study.
    Szadkowska A; Michalak A; Chylińska-Frątczak A; Baranowska-Jaźwiecka A; Koptas M; Pietrzak I; Hogendorf A; Zmysłowska A; Młynarski W; Mianowska B
    J Pediatr Endocrinol Metab; 2018 Oct; 31(10):1073-1079. PubMed ID: 30240358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional and longitudinal relationships of body mass index with glycemic control in children and adolescents with type 1 diabetes mellitus.
    Nansel TR; Lipsky LM; Iannotti RJ
    Diabetes Res Clin Pract; 2013 Apr; 100(1):126-32. PubMed ID: 23339757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of factors determining an HbA1c concentration ≤7.5% in patients with type 1 diabetes.
    Yamada E; Okada S; Nakajima Y; Bastie C; Tagaya Y; Osaki A; Shimoda Y; Shibusawa R; Saito T; Ozawa A; Yamada M
    J Diabetes; 2018 Feb; 10(2):140-147. PubMed ID: 28544548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-Variate Longitudinal Patterns of Metabolic Control, Body Mass Index, and Insulin Dose during Puberty in a Type 1 Diabetes Cohort: A Group-Based Multitrajectory Analysis.
    Schwandt A; Kuss O; Dunstheimer D; Karges B; Kapellen T; Meissner T; Witsch M; Flury M; Straubinger S; Holl RW;
    J Pediatr; 2020 Mar; 218():64-71.e3. PubMed ID: 31952845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proportion of Basal to Total Insulin Dose Is Associated with Metabolic Control, Body Mass Index, and Treatment Modality in Children with Type 1 Diabetes-A Cross-Sectional Study with Data from the International SWEET Registry.
    Rasmussen VF; Vestergaard ET; Schwandt A; Beltrand J; Rami-Merhar B; O'Riordan SMP; Jarosz-Chobot P; Castro-Correia C; Gevers EF; Birkebæk NH
    J Pediatr; 2019 Dec; 215():216-222.e1. PubMed ID: 31345576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes.
    Fujishima Y; Maeda N; Inoue K; Kashine S; Nishizawa H; Hirata A; Kozawa J; Yasuda T; Okita K; Imagawa A; Funahashi T; Shimomura I
    Cardiovasc Diabetol; 2012 Sep; 11():107. PubMed ID: 22973968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of newly diagnosed adults with type 1 diabetes in the UK and evolution of glycaemic control, body mass index and Charlson comorbidity index over the first 5 years after diagnosis.
    Ramtoola S; Nyeland ME; Jacobsen J; Ploug UJ; Kragh N; Zimmermann E
    Prim Care Diabetes; 2020 Aug; 14(4):349-355. PubMed ID: 31668975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns in Body Mass Index Changes in Children after Type 1 Diabetes Mellitus Diagnosis.
    Tenenbaum Weiss Y; Friger M; Haim A; Hershkovitz E
    Isr Med Assoc J; 2023 Feb; 25(2):137-142. PubMed ID: 36841984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviour.
    de Boer SA; Lefrandt JD; Petersen JF; Boersma HH; Mulder DJ; Hoogenberg K
    Int J Clin Pharm; 2016 Feb; 38(1):144-51. PubMed ID: 26597956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.
    Fountoulakis S; Papanastasiou L; Gryparis A; Markou A; Piaditis G
    Hormones (Athens); 2015; 14(4):632-43. PubMed ID: 26188234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Metformin Added to Insulin in Adolescents with Type 1 Diabetes: An Exploratory Crossover Randomized Trial.
    Yang D; Yan J; Deng H; Yang X; Luo S; Zheng X; Lv J; Liang W; Hong M; Wu Z; Yao B; Weng J; Xu W
    J Diabetes Res; 2020; 2020():7419345. PubMed ID: 33457425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control.
    Soliman AT; Omar M; Assem HM; Nasr IS; Rizk MM; El Matary W; El Alaily RK
    Metabolism; 2002 Mar; 51(3):292-6. PubMed ID: 11887162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and linear growth in diabetic children receiving insulin pigment.
    Mao L; Lu W; Ji F; Lv S
    J Pediatr Endocrinol Metab; 2011; 24(7-8):433-6. PubMed ID: 21932577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-variate trajectories of metabolic control, body mass index, and insulin dose: Heterogeneous response to initiation of pump therapy in youth with type 1 diabetes.
    Tauschmann M; Schwandt A; Prinz N; Becker M; Biester T; Hess M; Holder M; Karges B; Näke A; Kuss O; von Sengbusch S; Holl RW;
    Pediatr Diabetes; 2022 May; 23(3):330-340. PubMed ID: 35084795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of therapy with insulin glargine (lantus) on glycemic control in toddlers, children, and adolescents with diabetes.
    Hathout EH; Fujishige L; Geach J; Ischandar M; Maruo S; Mace JW
    Diabetes Technol Ther; 2003; 5(5):801-6. PubMed ID: 14633345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic, auxologic, and seasonal aspects of continuous subcutaneous insulin infusion therapy in children and young adults with type 1 diabetes.
    Hathout EH; McClintock T; Sharkey J; Kytsenko D; Hartwick N; Hadley-Scofield M; Torgeson S; Mace JW
    Diabetes Technol Ther; 2003; 5(2):175-81. PubMed ID: 12871607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.